🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 140755307
Business: Tvardi Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases.
Company Contact
- CEO
- Imran Alibhai
- CFO
- Dan Conn
- Headquarters
- 3 Sugar Creek Ctr. Blvd. Suite 525, Sugar Land, TX
- Phone
- 713-389-8654
- Investor Relations
- PJ Kelleher · 617-430-7579 · pkelleher@lifesciadvisors.com